LAURUS LABS
Back to Cashflow Statement
|
LAURUS LABS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-41 Cr | ₹93 Cr | ₹-29 Cr | ₹27 Cr | ₹47 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LAURUS LABS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-41 Cr |
| Mar2024 | ₹93 Cr |
| Mar2023 | ₹-29 Cr |
| Mar2022 | ₹27 Cr |
| Mar2021 | ₹47 Cr |
How is Net Cash Inflow / Outflow of LAURUS LABS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-41 Cr | Negative | |
| Mar2024 | ₹93 Cr | Positive | |
| Mar2023 | ₹-29 Cr | Negative | |
| Mar2022 | ₹27 Cr | -42.15 | |
| Mar2021 | ₹47 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹54,187.1 Cr | 2% | 8.3% | 79.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 2% |
8.3% |
79.3% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses